NiPPeR Randomised Trial - Child Follow Up Study
Launched by UNIVERSITY OF SOUTHAMPTON · Jun 27, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All children still participating in the NiPPeR study at 6-8 years.
- Exclusion Criteria:
- • Known significant congenital anomaly or genetic condition that influences child growth or neurodevelopment.
About University Of Southampton
The University of Southampton is a leading research institution in the United Kingdom, renowned for its commitment to advancing medical and scientific knowledge. With a strong emphasis on innovation and interdisciplinary collaboration, the university conducts a wide range of clinical trials aimed at improving patient care and health outcomes. Its dedicated team of researchers and clinicians leverage cutting-edge technologies and methodologies to explore new treatments and interventions, contributing significantly to the field of healthcare. Through rigorous ethical standards and a focus on translational research, the University of Southampton strives to translate scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Southampton, Hampshire, United Kingdom
Auckland, , New Zealand
Patients applied
Trial Officials
Wayne S Cutfield, MB MD FRACP
Principal Investigator
The University of Auckland
Shiao-Yng Chan, MD PhD FRCOG
Principal Investigator
National University of Singapore
Keith M Godfrey, BM PhD FRCP
Principal Investigator
MRC Lifecourse Epidemiology Centre, University of Southampton
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported